Image For Activity Cover
Module 6: Integrating Opioid Use Disorder Treatment in Clinical Care
Description
This module discusses models for integrating opioid use disorder (OUD) pharmacotherapy into primary care settings, reviews keys to successful OUD pharmacotherapy implementation in clinical practice, and identifies strategies for preventing diversion of buprenorphine/naloxone. Participants are encouraged to adapt this information for use in their own clinical practices.
Target Audience
Physicians, nurses, and healthcare teams who are treating patients with substance use disorder (SUD).
Presenters
P. Todd Korthuis, MD, MPH | Professor of Medicine; Chief, Section of Addiction Medicine; Oregon Health and Science University
Objectives

At the conclusion of this activity participants should be able to:

  • Identify models for integrating opioid use disorder (OUD) pharmacotherapy into primary care settings
  • Review keys to successful OUD pharmacotherapy implementation in clinical practice
  • Identify strategies for preventing diversion of buprenorphine/naloxone

Core Competencies as a result of participating in this activity:   
Interpersonal Skills and Communication
Medical Knowledge
Patient Care
 
Method of participation in the activity
In order to receive maximum credit, learners must:

1. Review the materials provided in this module.
2. Earn a minimum cumulative score of 80% on the post-test.
3. Complete an evaluation to assess satisfaction and plans for individual and/or team practice change.
4. Follow instructions at the end of the course regarding how to retrieve a certificate.*

*Credit will not be awarded unless all components of the program are completed. Partial credit will not be awarded.
Summary
Availability: Retired
Cost: FREE
Credit Offered:
No Credit Offered
Recommended
 
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.



Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

 
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email PCSS-MOUD.

ORN
opioidresponsenetwork.org

Powered By